Powered by

Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development

Feb 25, 2021 - Business Wire
Board and Executive Moves-Product Launch

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210225005836/en/

Thomas Bonnefont (Photo: Median Technologies)

Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created position of Chief Operating and Commercial Officer of the iBiopsy® Business Unit as well as the appointment of Mike Doherty as Sr. Strategy Advisor, iBiopsy® Product Develop...